Polymerizable dental materials such as filling composites, for example, exhibit a certain volume shrinkage during the polymerization reaction which is not totally avoidable, even with the skillful selection of monomers and the addition of inorganic fillers. Despite the use of adhesives, which are intended to ensure optimum bonding of the filling material to the tooth substance, this shrinkage can lead to formation of peripheral gaps, resulting in infiltration of microorganisms and secondary dental caries.
In this case, silver amalgam traditionally used as a dental material has an advantage, in that the antimicrobial properties of the amalgam substituents permit little or no secondary dental caries in spite of the pronounced tendency of the amalgam to form peripheral gaps.
The general and patent literatures contain numerous references to germicidal additives such as antibiotics, for example, to remedy this shortcoming of filling composites. Another problem is the anticipated resistance of the oral microflora to widely used antibiotics. Furthermore, this creates a practical problem for the manufacturer prior to marketing, since the requirements for registering an antibiotic may change as a result of the administration, and a medicinal product may lead to a drug with much more involved registration procedures.
Silver is known as a germicidal additive. However, silver is generally used not in the elemental form, but rather in the form of glass compositions (U.S. Pat. No. 6,593,260 B2, Ishizuka Garasu Kabushiki Kaisha), core-shell particles (U.S. Pat. No. 5,180,585, DuPont de Nemours), co-dosages of core-shell particles (U.S. Pat. No. 5,180,585, DuPont de Nemours), co-dosages of silicic acid (EP 1 083 146 A1, Degussa), complexed silver compounds (U.S. Pat. No. 5,985,308, Westham Technologies) applied to zeolites, etc.
Porous silver particles having diameters in the lower micron range are also known (DE 101 46 050 A1, WO 03/024494 A1, DE 102 05 600 A1, WO 02/17984 A1).
The silver particles proposed therein are generally several microns in diameter, and are also usually aggregated/agglomerated. The material therefore always has a dark intrinsic color. Thus, most of the silver materials described in these documents are not considered for use in tooth-colored dental materials, since, even in low concentrations, product characteristics such as color and transparency may be adversely affected.
To avoid such disadvantages, a polymerizable dental material is proposed which contains nanoscale silver particles as an antimicrobial additive which
The antimicrobial effect may be achieved with 1 ppm silver, in particular 10 ppm, and particularly preferably 100 ppm silver. The maximum proportion of silver may be as high as 10% by weight, and preferably is less than 5% by weight, particularly preferably less than 2% by weight.
The particles preferably exhibit at least one of the following additional features, namely, that they:
The proposed material has the following advantages:
A form of nanoscalar silver that is suitable for the materials according to the invention is marketed by Bio-Gate Bioinnovative Materials, Nuremberg. Recommended applications are coatings for textiles, fabrics, and bone implant materials, and adhesive and coating substances.
The silver preferably is contained in the dental material in a proportion of 0.05 to 0.5%.
The materials according to the invention are suitable in the field of dentistry as filling composites, prosthetic base materials, adhesives, veneer composites for crowns and bridges, and materials for artificial teeth, for example.
The following exemplary embodiment explains the invention without being limited thereto:
A sample was withdrawn from the “Venus/Heraeus Kulzer” dental filling composite material having the following components:
Ag nanoparticles (BioGate, Erlangen) having an average diameter of approximately 5 nm were homogeneously incorporated into the remaining compound in a concentration of approximately 50 ppm, using a kneader for a period of 30 minutes.
An additional sample was withdrawn and cured using a Translux Energy lamp.
There was no difference in color between the two cured samples.
Of course, the silver nanoparticles or the dispersion thereof may also be incorporated at a suitable point during the production process for the filling composite.
Number | Date | Country | Kind |
---|---|---|---|
103 59 338.1 | Dec 2003 | DE | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/EP04/14149 | 12/13/2004 | WO | 4/12/2007 |